Dr. Jose Celedon reports
AURORA CANNABIS ANNOUNCES COLLABORATION ON GENOME BC-FUNDED PROJECT ADDRESSING DISTINCT CANNABIS AROMAS
A research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome B.C.), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, genomics-enabled aroma breeding in cannabis, will directly support Aurora Cannabis Inc.'s genetics work. The project is led by Dr. Jose Celedon, principal scientist, breeding and genetics, at Aurora, and Dr. Joerg Bohlmann, a professor at UBC, and is focused on validating genetic and chemical markers for fruity aroma in cannabis. This meaningful genetics research aligns with Aurora's breeding goals and will enable the company to enhance its breeding program with greater accuracy and efficiency on consumer-focused traits, positively impacting future innovation.
"Through this work Aurora will deepen our understanding of cannabis genetics with a focus on aromas, a leading driver of consumer preference that directly impacts the user experience," said Dr. Jose Celedon, director, breeding and genetics at Aurora. "By collaborating with UBC on this Genome B.C. funded project, we are able to fully execute this aroma research without the typical financial constraints, allowing us to continue simultaneous work on additional important breeding traits, such as yield, potency and disease resistance. We are eager to see the outcomes of our work and the impact on the future of cannabis breeding."
Aroma is a distinct characteristic of cannabis and an important aspect of consumer inclination. As a leader with one of the most advanced cannabis genetic libraries globally, Aurora will move beyond sensory analysis and into validated aroma markers with this research. Recently, Aurora patented a series of genetic and chemical markers for fruity aroma, identified through its CanD diversity panel. This collaboration will allow Aurora to validate these markers using cutting-edge approaches that would otherwise require significant financing. The data generated from this work will support the discovery and launch of cultivars with unique and improved aromas, alongside high yield and potency.
Aurora's in-kind contributions to the project include conducting sensory analysis of fruity aromas and leading bioinformatic analyses with in-house software. UBC's contributions to the project through Genome B.C. funding, will involve sequencing transcriptomes, analyzing the volatile chemistry and conducting functional characterization of the genes responsible for fruity aromas in cannabis. If successful, the methods developed in this project will be adapted to explore other aromas and could further strengthen Aurora's aroma-related intellectual property portfolio.
This collaboration with UBC underscores Aurora's commitment to innovation and scientific advancement in the cannabis sector. Aurora continues to push the boundaries of cannabis research and development, setting new standards for product quality and consumer satisfaction.
About Aurora Cannabis
Inc.
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co.; as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.
Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.